about
Noninvasive Diagnosis of Nonalcoholic Fatty Liver Disease and Quantification of Liver Fat Using a New Quantitative Ultrasound TechniqueUltrasound Elastography and MR Elastography for Assessing Liver Fibrosis: Part 1, Principles and Techniques.Consensus report from the 7th International Forum for Liver Magnetic Resonance ImagingHypotensive patients with blunt abdominal trauma: performance of screening USWhole-body CT screening: spectrum of findings and recommendations in 1192 patientsReview article: epidemiology, pathogenesis and potential treatments of paediatric non-alcoholic fatty liver diseaseNon-invasive screening of diabetics in primary care for NAFLD and advanced fibrosis by MRI and MRE.Magnetic resonance elastography for staging liver fibrosis in non-alcoholic fatty liver disease: a diagnostic accuracy systematic review and individual participant data pooled analysisComparative diagnostic accuracy of magnetic resonance elastography vs. eight clinical prediction rules for non-invasive diagnosis of advanced fibrosis in biopsy-proven non-alcoholic fatty liver disease: a prospective study.Ultrasound Elastography and MR Elastography for Assessing Liver Fibrosis: Part 2, Diagnostic Performance, Confounders, and Future Directions.Ezetimibe for the treatment of nonalcoholic steatohepatitis: assessment by novel magnetic resonance imaging and magnetic resonance elastography in a randomized trial (MOZART trial)Magnetic resonance elastography predicts advanced fibrosis in patients with nonalcoholic fatty liver disease: a prospective study.Effect of flip angle on the accuracy and repeatability of hepatic proton density fat fraction estimation by complex data-based, T1-independent, T2*-corrected, spectrum-modeled MRI.LI-RADS (Liver Imaging Reporting and Data System): summary, discussion, and consensus of the LI-RADS Management Working Group and future directions.In vivo breath-hold (1) H MRS simultaneous estimation of liver proton density fat fraction, and T1 and T2 of water and fat, with a multi-TR, multi-TE sequence.Gadolinium-DTPA-dextran: a macromolecular MR blood pool contrast agent.Pediatric nonalcoholic fatty liver disease: a critical appraisal of current data and implications for future research.Relaxation effects in the quantification of fat using gradient echo imaging.Fatty liver disease: MR imaging techniques for the detection and quantification of liver steatosis.Nonalcoholic fatty liver disease: diagnostic and fat-grading accuracy of low-flip-angle multiecho gradient-recalled-echo MR imaging at 1.5 T.Effect of PRESS and STEAM sequences on magnetic resonance spectroscopic liver fat quantification.Nephrogenic systemic fibrosis in liver disease: a systematic review.SAFETY study: alanine aminotransferase cutoff values are set too high for reliable detection of pediatric chronic liver diseaseEstimation of hepatic proton-density fat fraction by using MR imaging at 3.0 TSpatial distribution of MRI-Determined hepatic proton density fat fraction in adults with nonalcoholic fatty liver disease.Combination of complex-based and magnitude-based multiecho water-fat separation for accurate quantification of fat-fraction.Association between novel MRI-estimated pancreatic fat and liver histology-determined steatosis and fibrosis in non-alcoholic fatty liver disease.Assessment of liver fat quantification in the presence of ironSebelipase alfa over 52 weeks reduces serum transaminases, liver volume and improves serum lipids in patients with lysosomal acid lipase deficiency.Bone mineral density and atherosclerosis: the Multi-Ethnic Study of Atherosclerosis, Abdominal Aortic Calcium Study.Decoding global gene expression programs in liver cancer by noninvasive imaging.CT and MR imaging diagnosis and staging of hepatocellular carcinoma: part I. Development, growth, and spread: key pathologic and imaging aspects.CT and MR imaging diagnosis and staging of hepatocellular carcinoma: part II. Extracellular agents, hepatobiliary agents, and ancillary imaging featuresAcetaminophen pharmacokinetics in children with nonalcoholic fatty liver disease.Automated registration of sequential breath-hold dynamic contrast-enhanced MR images: a comparison of three techniques.Quantification of liver iron with MRI: state of the art and remaining challenges.Indeterminate observations (liver imaging reporting and data system category 3) on MRI in the cirrhotic liver: fate and clinical implications.Effect of weight loss on magnetic resonance imaging estimation of liver fat and volume in patients with nonalcoholic steatohepatitis.Screening ultrasound in blunt abdominal trauma.Cross-sectional investigation of correlation between hepatic steatosis and IVIM perfusion on MR imaging.
P50
Q27318751-0635F95E-74C1-4671-B648-461540F8E2C8Q28081275-2E156383-B987-49DF-8B36-86C830D03DF8Q28088807-5408C769-9486-4305-9C7F-D4F722A5F002Q28242417-05BB4A05-A56D-4650-A792-FB94B3186A23Q28272937-76535B72-6E09-4645-BDF8-F7C47AAF065FQ28275665-944488C7-5380-4880-BCFE-D06A9163BFF3Q30366569-63122BE3-C9EB-4297-B918-E8A66177E38BQ30372813-FBEC4200-F424-4E15-A96C-C7BC3A0B0F5BQ30382172-C324CCE7-3FF7-4C7F-84F9-4B53F4A623F2Q30387965-6180BB2D-2D56-4DF0-99CB-8041F5EF4D25Q30413592-2433212E-D22F-4E74-AFBA-7E64782E4209Q30418856-082F584E-C2BE-476F-9F61-2D75515922ABQ30618074-3D099BD5-CB5E-4ECA-954D-D8626000F5C6Q30837374-D0BF8F2B-18A4-454C-971D-CD998C6282B7Q30976946-A2D202E8-0467-472F-96E4-14AED8221F91Q30978372-B0999FCA-598B-41B6-BC0A-3450824C945CQ31065792-E5BFABE2-538A-497A-BAB1-4BDEE656695AQ31140579-79EE0ECA-16E5-43DE-8E23-C618329BFC16Q33402851-4FB4773D-31E4-414B-AF56-E214E4037471Q33409801-C5381093-241E-4792-9071-C4C98878D32EQ33474978-27269D01-A024-4736-879B-779D5F3A584FQ33748364-C23F32EF-3475-4C35-9E36-7840C28DB91BQ33759095-C7BEF0DC-5CD7-446E-8462-88691B81B4EAQ33787851-2F288C6D-A616-4BF5-A82C-5A8F7366B706Q33851755-02F54DDB-8B24-493E-AB3B-2786CDA7FF87Q33939919-7BB5E495-BCDC-4AB9-A027-036365461216Q34060362-B1351A22-BB08-4916-BA93-436F09E9E68CQ34074615-1226351E-D305-4DAD-8714-9AFE42E3AB07Q34373792-48024CFA-FB34-4E08-8D53-2419906E61ADQ34626997-DF9A8D91-AAD9-4A05-8427-156D0E9AB7A4Q34630291-3ACA42BD-F6BE-4790-AD72-D3C9BCE193DDQ34681076-8C66F22B-71AA-41E9-9085-7ADF25994809Q34682228-64FAFA01-E3CF-4F99-80A1-AB2F5E9C13D1Q34690684-692B1680-381E-492A-8AC7-6D31C09C4D10Q35000647-5B5C96D2-3D2E-4CF6-9B5F-DC0C0955D2F6Q35020698-16DF354A-7CC6-4FAC-AF2F-1CDF7C0A9496Q35023769-6591954E-FA3C-4205-B2AC-5CB629CFDF9BQ35096971-9885C086-7EAA-4867-AC71-5E6AAC7BA130Q35702226-F56064D9-64D7-471A-BE65-07F89C2DFC19Q35892454-21C16180-001B-47EB-8C8B-29A0FC2548C0
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Claude B. Sirlin
@ast
Claude B. Sirlin
@en
Claude B. Sirlin
@es
Claude B. Sirlin
@nl
Claude B. Sirlin
@sl
type
label
Claude B. Sirlin
@ast
Claude B. Sirlin
@en
Claude B. Sirlin
@es
Claude B. Sirlin
@nl
Claude B. Sirlin
@sl
prefLabel
Claude B. Sirlin
@ast
Claude B. Sirlin
@en
Claude B. Sirlin
@es
Claude B. Sirlin
@nl
Claude B. Sirlin
@sl
P106
P1153
7003768876
P21
P31
P496
0000-0002-6639-9072